Evidence map›Paper›PMID 32703820›Full record

ArticleThe European respiratory journal2020

Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa".

Erika Mohr-Holland, Anja Reuter, Jennifer Hughes, Johnny Daniels, Busisiwe Beko, Goodman Makhanda, Virginia De Avezedo, Yulene Kock, Helen Cox, Jennifer Furin and 3 more

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in The European respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Erika Mohr-HollandMédecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project and Coordination Office, Cape Town, South Africa msfocb-khayelitsha-drtb-epi@brussels.msf.org.
Anja ReuterMédecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project and Coordination Office, Cape Town, South Africa.
Jennifer HughesMédecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project and Coordination Office, Cape Town, South Africa.ORCID 0000-0002-5349-9509
Johnny DanielsMédecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project and Coordination Office, Cape Town, South Africa.
Busisiwe BekoMédecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project and Coordination Office, Cape Town, South Africa.
Goodman MakhandaSouth African Medical Research Council, Cape Town, South Africa.
Virginia De AvezedoCity of Cape Town Health Department, Cape Town, South Africa.
Yulene KockNational Department of Health, Pretoria, South Africa.
Helen CoxInstitute of Infectious Disease and Molecular Medicine and Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.
Jennifer FurinDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Laura Trivino DuranMédecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project and Coordination Office, Cape Town, South Africa.
Petros IsaakidisMédecins Sans Frontières, South African Medical Unit (SAMU), Cape Town, South Africa.
Gabriella FerlazzoMédecins Sans Frontières, South African Medical Unit (SAMU), Cape Town, South Africa.
Médecins Sans Frontières · ZACity of Cape Town · ZADepartment of Health · ZAHarvard University · USSouth African Medical Research Council · ZAUniversity of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NitroimidazolesTuberculosis, Multidrug-ResistantHumansOxazolesRetrospective StudiesRifampinSouth AfricaNitroimidazolesOPC-67683OxazolesRifampin

Identifiers

PMID32703820
OpenAlexW3044571078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.